Cholesterol content drives distinct pharmacological behaviours of µ-opioid receptor in different microdomains of the CHO plasma membrane

References

• Pike LJ. Lipid rafts: heterogeneity on the high seas. Biochem J 2004; 378: 281–292
   PubMed Web of Science ®Google Scholar
• Ge M, Gidwani A, Brown HA, Holowka D, Baird B, Freed JH. Ordered and disordered phases coexist in plasma membrane vesicles of RBL-2H3 mast cells. An ESR study. Biophys J 2003; 85: 1278–1288
   PubMed Web of Science ®Google Scholar
• London E. Insights into lipid raft structure and formation from experiments in model membranes. Curr Opin Struct Biol 2002; 12: 480–486
   PubMed Web of Science ®Google Scholar
• Schuck S, Honsho M, Ekroos K, Shevchenko A, Simons K. Resistance of cell membranes to different detergents. Proc Natl Acad Sci USA 2003; 100: 5795–5800
   PubMed Web of Science ®Google Scholar
• Ipsen JH, Karlstrom G, Mouritsen OG, Wennerstrom H, Zuckermann MJ. Phase equilibria in the phosphatidylcholine-cholesterol system. Biochim Biophys Acta 1987; 905: 162–172
   PubMed Web of Science ®Google Scholar
• Gandhavadi M, Allende D, Vidal A, Simon SA, McIntosh TJ. Structure, composition, and peptide binding properties of detergent soluble bilayers and detergent resistant rafts. Biophys J 2002; 82: 1469–1482
   PubMedGoogle Scholar
• Gimpl G, Fahrenholz F. Cholesterol as stabilizer of the oxytocin receptor. Biochim Biophys Acta 2002; 1564: 384–392
   Google Scholar
• Scanlon SM, Williams DC, Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry 2001; 40: 10507–10513
   PubMedGoogle Scholar
• Nunez MT, Glass J. Reconstitution of the transferrin receptor in lipid vesicles. Effect of cholesterol on the binding of transferrin. Biochemistry 1982; 21: 4139–4143
   PubMed Web of Science ®Google Scholar
• Pike LJ, Casey L. Cholesterol levels modulate EGF receptor-mediated signaling by altering receptor function and trafficking. Biochemistry 2002; 41: 10315–10322
   PubMedGoogle Scholar
• Westover EJ, Covey DF, Brockman HL, Brown RE, Pike LJ. Cholesterol depletion results in site-specific increases in epidermal growth factor receptor phosphorylation due to membrane level effects. Studies with cholesterol enantiomers. J Biol Chem 2003; 278: 51125–51133
   Google Scholar
• Polozova A, Litman BJ. Cholesterol dependent recruitment of di22:6-PC by a G protein-coupled receptor into lateral domains. Biophys J 2000; 79: 2632–2643
   Google Scholar
• Niu SL, Mitchell DC, Litman BJ. Manipulation of cholesterol levels in rod disk membranes by methyl-beta-cyclodextrin: effects on receptor activation. J Biol Chem 2002; 277: 20139–20145
   Google Scholar
• Niu SL, Mitchell DC, Lim SY, Wen ZM, Kim HY, Salem N, Jr, Litman BJ. Reduced G protein-coupled signaling efficiency in retinal rod outer segments in response to N-3 fatty acid deficiency. J Biol Chem 2004; 279: 31098–31104
   PubMed Web of Science ®Google Scholar
• Pang L, Graziano M, Wang S. Membrane cholesterol modulates galanin-GalR2 interaction. Biochemistry 1999; 38: 12003–12011
   PubMed Web of Science ®Google Scholar
• Harikumar KG, Puri V, Singh RD, Hanada K, Pagano RE, Miller LJ. Differential Effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor. J Biol Chem 2005; 280: 2176–2185
   Google Scholar
• Emmerson PJ, Clark MJ, Medzihradsky F, Remmers AE. Membrane microviscosity modulates mu-opioid receptor conformational transitions and agonist efficacy. J Neurochem 1999; 73: 289–300
   Google Scholar
• Farahbakhsh ZT, Deamer DW, Lee NM, Loh HH. Enzymatic reconstitution of brain membrane and membrane opiate receptors. J Neurochem 1986; 46: 953–962
   Google Scholar
• Lagane B, Gaibelet G, Meilhoc E, Masson JM, Cezanne L, Lopez A. Role of sterols in modulating the human mu-opioid receptor function in Saccharomyces cerevisiae. J Biol Chem 2000; 275: 33197–33200
   PubMedGoogle Scholar
• Pucadyil TJ, Chattopadhyay A. Cholesterol modulates ligand binding and G-protein coupling to serotonin (1A) receptors from bovine hippocampus. Biochim Biophys Acta 2004; 1663: 188–200
   PubMed Web of Science ®Google Scholar
• Gimpl G, Klein U, Reilander H, Fahrenholz F. Expression of the human oxytocin receptor in baculovirus-infected insect cells: high-affinity binding is induced by a cholesterol-cyclodextrin complex. Biochemistry 1995; 34: 13794–13801
   PubMed Web of Science ®Google Scholar
• Klein U, Gimpl G, Fahrenholz F. Alteration of the myometrial plasma membrane cholesterol content with beta-cyclodextrin modulates the binding affinity of the oxytocin receptor. Biochemistry 1995; 34: 13784–13793
   PubMed Web of Science ®Google Scholar
• Cherezov V, Rosenbaum DM, Hanson MA, Rasmussen SG, Thian FS, Kobilka TS, Choi HJ, Kuhn P, Weis WI, Kobilka BK, Stevens RC. High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor. Science 2007; 318: 1258–1265
   PubMed Web of Science ®Google Scholar
• Gimpl G, Fahrenholz F. Human oxytocin receptors in cholesterol-rich vs. cholesterol-poor microdomains of the plasma membrane. Eur J Biochem 2000; 267: 2483–2497
   PubMedGoogle Scholar
• Cézanne L, Navarro L, Tocanne JF. Isolation of the plasma membrane and organelles from Chinese hamster ovary cells. Biochim Biophys Acta 1992; 1112: 205–214
   Google Scholar
• Zak B, Dickenman RC, White EG, Burnett H, Cherney PJ. Rapid estimation of free and total cholesterol. Am J Clin Pathol 1954; 24: 1307–1315
   PubMed Web of Science ®Google Scholar
• Leborgne N, Cézanne L, Teulières C, Canut H, Tocanne JF, Boudet AM. Lateral and rotational mobilities of lipids in specific cellular membranes of Eucalyptus gunnii. Plant Physiol 1992; 100: 246–254
   Google Scholar
• Christian AE, Haynes MP, Phillips MC, Rothblat GH. Use of cyclodextrins for manipulating cellular cholesterol content. J Lipid Res 1997; 38: 2264–2272
   PubMed Web of Science ®Google Scholar
• Huang P, Xu W, Yoon SI, Chen C, Chong PL, Liu-Chen LY. Cholesterol reduction by methyl-beta-cyclodextrin attenuates the delta opioid receptor-mediated signaling in neuronal cells but enhances it in non-neuronal cells. Biochem Pharmacol 2007; 73: 534–549
   Google Scholar
• Prendergast FG, Haugland RP, Callahan PJ. 1-[4-(trimethylamino)phenyl]-6-phenylhexa-1,3,5-triene: synthesis, fluorescence properties and use as fluorescence probe of lipid bilayers. Biochemistry 1981; 20: 7333–7338
   PubMed Web of Science ®Google Scholar
• Van Blitterswijk WJ, Van Hoeven RP, Van der Meer BW. Lipid structural order parameters (reciprocal of fluidity) in biomembranes derived from steady-state fluorescence polarization measurements. Biochim Biophys Acta 1981; 644: 323–332
   PubMed Web of Science ®Google Scholar
• Gaibelet G, Capeyrou R, Dietrich G, Emorine LJ. Identification in the mu-opioid receptor of cysteine residues responsible for inactivation of ligand binding by thiol alkylating and reducing agents. FEBS Lett 1997; 408: 135–140
   Google Scholar
• Gaibelet G, Meilhoc E, Riond J, Saves I, Exner T, Liaubet L, Nurnberg B, Masson JM, Emorine LJ. Nonselective coupling of the human mu-opioid receptor to multiple inhibitory G-protein isoforms. Eur J Biochem 1999; 261: 517–523
   Google Scholar
• Cantor RS. The influence of membrane lateral pressures on simple geometric models of protein conformational equilibria. Chem Phys Lipids 1999; 101: 45–56
   PubMed Web of Science ®Google Scholar
• Fukuda K, Kato S, Mori K. Location of regions of the opioid receptor involved in selective agonist binding. J Biol Chem 1995; 270: 6702–6709
   Google Scholar
• Wieland C, Jakobs KH, Wieland T. Altered guanine nucleoside triphosphate binding to transducin by cholera toxin-catalysed ADP-ribosylation. Cell Signal 1994; 6: 487–492
   Google Scholar
• Gray RE, Munks MW, Haynes RR, Olsen GD. Mu opioid receptor efficacy and potency of morphine-6-glucuronide in neonatal guinea pig brainstem membranes: comparison with transfected CHO cells. Brain Res Bull 2001; 54: 499–505
   Google Scholar
• Garner AE ,Smith A ,Hooper NM. 2007. Visualization of detergent solubilisation of membranes: Implications for the isolation of rafts Biophys J. doi:10:1529/biophysj.1107.114108.
   Google Scholar
• Bagnat M, Keranen S, Shevchenko A, Simons K. Lipid rafts function in biosynthetic delivery of proteins to the cell surface in yeast. Proc Natl Acad Sci USA 2000; 97: 3254–3259
   PubMed Web of Science ®Google Scholar
• Samama P, Cotecchia S, Costa T, Lefkowitz RJ. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. J Biol Chem 1993; 268: 4625–4636
   PubMed Web of Science ®Google Scholar
• Berchiche YA, Chow KY, Lagane B, Leduc M, Percherancier Y, Fujii N, Tamamura H, Bachelerie F, Heveker N. Direct assessment of CXCR4 mutant conformations reveals complex link between receptor structure and G(alpha)(i) activation. J Biol Chem 2007; 282: 5111–5115
   PubMed Web of Science ®Google Scholar
• Babiychuk B, Draeger A. Biochemical characterization of detergent-resistant membranes: a systematic approach. Biochem J 2006; 397: 407–416
   PubMed Web of Science ®Google Scholar
• Li XM, Momsen MM, Smaby JM, Brockman HL, Brown RE. Cholesterol decreases the interfacial elasticity and detergent solubility of sphingomyelins. Biochemistry 2001; 40: 5954–5963
   Google Scholar
• Zhao H, Loh HH, Law PY. Adenylyl cyclase superactivation induced by long-term treatment with opioid agonist is dependent on receptor localized within lipid rafts and is independent of receptor internalization. Mol Pharmacol 2006; 69: 1421–1432
   Google Scholar
• André A, Gaibelet G, Le Guyader L, Welby M, Lopez A, Lebrun C. 2008. Membrane partitioning of various delta-opioid receptor forms before and after agonist activations: the effect of cholesterol. Biochim Biophys Acta: DOI: 10.1016/j.bbamem.2008.1003.1017.
   Google Scholar
• Salamon Z, Cowell S, Varga E, Yamamura HI, Hruby VJ, Tollin G. Plasmon resonance studies of agonist/antagonist binding to the human delta-opioid receptor: new structural insights into receptor-ligand interactions. Biophys J 2000; 79: 2463–2474
   Web of Science ®Google Scholar
• Le Guyader L, Le Roux C, Mazères S, Gaspard-Iloughmane H, Gornitzka H, Millot C, Mingotaud C, Lopez A. Changes of the membrane lipid organization characterized by means of a new cholesterol-pyrene probe. Biophys J 2007; 93: 4462–4473
   Google Scholar
• Saulière A, Gaibelet G, Millot C, Mazères S, Lopez A, Salomé L. Diffusion of the mu opioid receptor at the surface of human neuroblastoma SH-SY5Y cells is restricted to permeable domains. FEBS Lett 2006; 580: 5227–5231
   Google Scholar